Aramark (ARMK) EVP and CFO reports dividend-equivalent share grant

Rhea-AI Filing Summary

Aramark’s Executive Vice President and Chief Financial Officer reported a routine change in personal holdings. On 12/17/2025, the insider acquired 99.511 shares of common stock as dividend equivalent rights tied to previously awarded restricted stock units and performance stock units. These dividend equivalents were granted at a price of $0 and will vest on the same schedules as the underlying awards. Following this transaction, the officer directly beneficially owns 61,359.989 shares of Aramark common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Tarangelo James J.

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	99.511	$0.00	--

Holdings After Transaction: Common Stock — 61,359.989 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tarangelo James J.

(Last) (First) (Middle)

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		A		99.511(1)	A	$0	61,359.989	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and previously granted performance stock units that were determined to be earned held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) disclose in this Form 4?

Aramark disclosed that its Executive Vice President and Chief Financial Officer acquired 99.511 shares of common stock as dividend equivalent rights on 12/17/2025.

Who is the reporting person in the Aramark (ARMK) Form 4 filing and what is their role?

The reporting person is an Officer of Aramark, serving as EVP and CFO, and is required to report changes in beneficial ownership of the company’s equity.

How many Aramark (ARMK) shares does the insider own after the reported transaction?

After the reported transaction, the insider directly beneficially owns 61,359.989 shares of Aramark common stock.

What are the 99.511 Aramark (ARMK) shares reported as acquired in this Form 4?

The 99.511 shares represent dividend equivalent rights that accrued on restricted stock units and previously granted performance stock units held by the reporting person.

At what price were the dividend equivalent rights in Aramark (ARMK) granted?

The dividend equivalent rights were reported as acquired at a price of $0, reflecting that they were credited as part of existing equity awards rather than purchased in the market.

When do the Aramark (ARMK) dividend equivalent rights reported in this Form 4 vest?

The filing states that these dividend equivalent rights vest on the same schedules as the underlying awards, meaning they follow the vesting of the related restricted stock units and performance stock units.